PL335652A1 - Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid - Google Patents
Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acidInfo
- Publication number
- PL335652A1 PL335652A1 PL98335652A PL33565298A PL335652A1 PL 335652 A1 PL335652 A1 PL 335652A1 PL 98335652 A PL98335652 A PL 98335652A PL 33565298 A PL33565298 A PL 33565298A PL 335652 A1 PL335652 A1 PL 335652A1
- Authority
- PL
- Poland
- Prior art keywords
- phenylprolidin
- ylidenomethyl
- indolo
- dichloro
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL335652A1 true PL335652A1 (en) | 2000-05-08 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98335652A PL335652A1 (en) | 1997-03-05 | 1998-03-03 | Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (es) |
| JP (1) | JP2001513796A (es) |
| KR (1) | KR20000075907A (es) |
| CN (1) | CN1249750A (es) |
| AP (1) | AP9901637A0 (es) |
| AR (1) | AR011178A1 (es) |
| AU (1) | AU6825198A (es) |
| BG (1) | BG103779A (es) |
| BR (1) | BR9808305A (es) |
| CA (1) | CA2282851A1 (es) |
| CO (1) | CO4940415A1 (es) |
| EA (1) | EA199900710A1 (es) |
| EE (1) | EE9900387A (es) |
| GB (1) | GB9704498D0 (es) |
| HR (1) | HRP980114A2 (es) |
| HU (1) | HUP0002109A2 (es) |
| ID (1) | ID24207A (es) |
| IL (1) | IL131489A0 (es) |
| IS (1) | IS5166A (es) |
| NO (1) | NO994303L (es) |
| NZ (1) | NZ337315A (es) |
| OA (1) | OA11154A (es) |
| PE (1) | PE51399A1 (es) |
| PL (1) | PL335652A1 (es) |
| SK (1) | SK119699A3 (es) |
| TR (1) | TR199902117T2 (es) |
| WO (1) | WO1998039327A1 (es) |
| YU (1) | YU43499A (es) |
| ZA (1) | ZA981791B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| EP3638234A1 (en) | 2017-06-12 | 2020-04-22 | Glytech LLC. | Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6825198A (en) | 1998-09-22 |
| JP2001513796A (ja) | 2001-09-04 |
| BR9808305A (pt) | 2000-05-16 |
| AR011178A1 (es) | 2000-08-02 |
| EA199900710A1 (ru) | 2000-04-24 |
| WO1998039327A1 (en) | 1998-09-11 |
| HRP980114A2 (en) | 1998-12-31 |
| YU43499A (sh) | 2000-12-28 |
| EP0966463A1 (en) | 1999-12-29 |
| BG103779A (en) | 2000-06-30 |
| TR199902117T2 (xx) | 2000-03-21 |
| HUP0002109A2 (hu) | 2001-04-28 |
| CA2282851A1 (en) | 1998-09-11 |
| NO994303D0 (no) | 1999-09-03 |
| IS5166A (is) | 1999-08-27 |
| PE51399A1 (es) | 1999-06-07 |
| NZ337315A (en) | 2001-02-23 |
| IL131489A0 (en) | 2001-01-28 |
| ID24207A (id) | 2000-07-13 |
| SK119699A3 (en) | 2000-05-16 |
| ZA981791B (en) | 1999-09-03 |
| EE9900387A (et) | 2000-04-17 |
| CN1249750A (zh) | 2000-04-05 |
| AP9901637A0 (en) | 1999-09-30 |
| KR20000075907A (ko) | 2000-12-26 |
| OA11154A (en) | 2003-04-16 |
| NO994303L (no) | 1999-11-03 |
| CO4940415A1 (es) | 2000-07-24 |
| GB9704498D0 (en) | 1997-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1026699A1 (en) | Crystalline form of omeprazole sodium salt | |
| HK1035711A1 (en) | New 3-aryl-2-hydroxypropionic acid derivative (i) | |
| IL139470A0 (en) | Oxyiminoalkanoic acid derivatives | |
| EG23980A (en) | Potassium salt of (s)-omeprazole | |
| PL345794A1 (en) | Aminomethylcarboxylic acid derivatives | |
| PL339659A1 (en) | Crystalline antimycotic polymorph | |
| AP2001002078A0 (en) | Crystalline forms of et02c-ch2(r)cgl-aze-pab-oh | |
| ZA957188B (en) | Use of 5-substituted pyridine- and hexahydroquinoline-3-carboxylic acid derivatives | |
| MXPA00012647A (es) | Derivados n-sustituidos de acido 5-oxiiminobarbiturico. | |
| PL340461A1 (en) | Derivatives of isothiazocarboxylic acid | |
| AP9901457A0 (en) | Novel dihydroxyexanoic acid derivatives | |
| AU1917899A (en) | Crystalline sodium phenytoin monohydrate | |
| HUP9801924A3 (en) | Combination containing sodium/hydrogen exchange inhibitors | |
| AU2212397A (en) | Solid hop acid salt compositions | |
| AU2674497A (en) | Crystallization of sodium carbonates using alcohols | |
| ITMI20000774A0 (it) | Cartuccia per la perforazione dell'orecchio | |
| PL335652A1 (en) | Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid | |
| AU1817700A (en) | 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 | |
| IL131676A0 (en) | 2-Substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives | |
| ZA200007084B (en) | Novel salts of N-tert-butylhydroxylamine. | |
| AUPP355498A0 (en) | Salt poultice | |
| AU1719700A (en) | Selective inhibitors of mmp-12 | |
| SI0991641T1 (en) | Crystalline form of omeprazole sodium salt | |
| AU1874600A (en) | Homopiperazine derivatives as selective emopamil inhibitors | |
| HU9700564D0 (en) | Solid, non-deliquescent formulations of sodium valproate |